• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.33% Nasdaq Up0.26%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    9.17 Down 0.22(2.34%) 12:13PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 40,572   10,457   13,467  
    Cost of Revenue -   -   -  
    Gross Profit 40,572   10,457   13,467  
    Operating Expenses
    Research Development57,792  34,095  21,369  
    Selling General and Administrative18,064  15,858  13,643  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (34,284) (39,496) (19,544)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,483  680  (43,500)
    Earnings Before Interest And Taxes(31,201)(36,140)(66,084)
    Interest Expense -   -   -  
    Income Before Tax(31,201)(36,140)(66,084)
    Income Tax Expense(2,098) -   -  
    Minority Interest(85)18  55  
    Net Income From Continuing Ops(26,587)(33,445)(67,067)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (29,188) (36,122) (66,028)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (29,188) (36,122) (66,028)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.